These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31640150)

  • 1. Targeting NRF2 for the Treatment of Friedreich's Ataxia: A Comparison among Drugs.
    Petrillo S; D'Amico J; La Rosa P; Bertini ES; Piemonte F
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31640150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of dilated cardiomyopathy in a mouse model of Friedreich's ataxia using N-acetylcysteine and identification of alterations in microRNA expression that could be involved in its pathogenesis.
    Chiang S; Huang MLH; Richardson DR
    Pharmacol Res; 2020 Sep; 159():104994. PubMed ID: 32534099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich's Ataxia.
    Petrillo S; Piermarini E; Pastore A; Vasco G; Schirinzi T; Carrozzo R; Bertini E; Piemonte F
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29057804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies in Friedreich's Ataxia.
    Zesiewicz TA; Hancock J; Ghanekar SD; Kuo SH; Dohse CA; Vega J
    Expert Rev Neurother; 2020 Dec; 20(12):1215-1228. PubMed ID: 32909841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
    Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
    Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia.
    La Rosa P; Petrillo S; Turchi R; Berardinelli F; Schirinzi T; Vasco G; Lettieri-Barbato D; Fiorenza MT; Bertini ES; Aquilano K; Piemonte F
    Redox Biol; 2021 Jan; 38():101791. PubMed ID: 33197769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich's Ataxia.
    La Rosa P; Bertini ES; Piemonte F
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
    Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
    Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy.
    Marmolino D; Acquaviva F; Pinelli M; Monticelli A; Castaldo I; Filla A; Cocozza S
    Cerebellum; 2009 Jun; 8(2):98-103. PubMed ID: 19104905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deferiprone for the treatment of Friedreich's ataxia.
    Pandolfo M; Hausmann L
    J Neurochem; 2013 Aug; 126 Suppl 1():142-6. PubMed ID: 23859349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia.
    Cotticelli MG; Xia S; Lin D; Lee T; Terrab L; Wipf P; Huryn DM; Wilson RB
    J Pharmacol Exp Ther; 2019 Apr; 369(1):47-54. PubMed ID: 30635474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.
    Anzovino A; Lane DJ; Huang ML; Richardson DR
    Br J Pharmacol; 2014 Apr; 171(8):2174-90. PubMed ID: 24138602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model.
    Shan Y; Schoenfeld RA; Hayashi G; Napoli E; Akiyama T; Iodi Carstens M; Carstens EE; Pook MA; Cortopassi GA
    Antioxid Redox Signal; 2013 Nov; 19(13):1481-93. PubMed ID: 23350650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in the Treatment Strategies of Friedreich's Ataxia: A Review of Potential Drug Candidates and their Underlying Mechanisms.
    Saini AK; Anil N; Vijay AN; Mangla B; Javed S; Kumar P; Ahsan W
    Curr Pharm Des; 2024; 30(19):1472-1489. PubMed ID: 38638052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frataxin deficiency leads to reduced expression and impaired translocation of NF-E2-related factor (Nrf2) in cultured motor neurons.
    D'Oria V; Petrini S; Travaglini L; Priori C; Piermarini E; Petrillo S; Carletti B; Bertini E; Piemonte F
    Int J Mol Sci; 2013 Apr; 14(4):7853-65. PubMed ID: 23574943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon Gamma Enhances Cytoprotective Pathways via Nrf2 and MnSOD Induction in Friedreich's Ataxia Cells.
    Luffarelli R; Panarello L; Quatrana A; Tiano F; Fortuni S; Rufini A; Malisan F; Testi R; Condò I
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1/AMPK, KEAP1, and GSK3β in the impairment of the NRF2 response.
    Sanz-Alcázar A; Portillo-Carrasquer M; Delaspre F; Pazos-Gil M; Tamarit J; Ros J; Cabiscol E
    Redox Biol; 2024 Oct; 76():103339. PubMed ID: 39243573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
    Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW
    Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in mitochondrial glutathione levels and protein thiol oxidation in ∆yfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia.
    Bulteau AL; Planamente S; Jornea L; Dur A; Lesuisse E; Camadro JM; Auchère F
    Biochim Biophys Acta; 2012 Feb; 1822(2):212-25. PubMed ID: 22200491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia.
    Sahdeo S; Scott BD; McMackin MZ; Jasoliya M; Brown B; Wulff H; Perlman SL; Pook MA; Cortopassi GA
    Hum Mol Genet; 2014 Dec; 23(25):6848-62. PubMed ID: 25113747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.